Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2026
상품코드:1939167
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
양성 전립선 비대증(BPH) 치료 기기·장비 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 13억 4,000만 달러에서 2026년에는 14억 3,000만 달러로, CAGR 6.3%로 확대할 전망입니다. 지난 수년간의 성장은 전립선비대증 유병률 증가, 비뇨기 질환에 대한 인식 개선, 경요도적 시술의 보급, 병원 비뇨기과 부서의 확대, 내시경 수술기구의 개선 등이 원인으로 추정됩니다.
양성 전립선 비대증(BPH) 치료 기기·장비 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 18억 6,000만 달러에 달하며, CAGR은 6.9%에 달할 전망입니다. 예측 기간의 성장 요인으로는 고령 남성 인구 증가, 저침습적 치료에 대한 선호도 증가, 외래 비뇨기과 클리닉의 확대, 레이저 치료 및 임플란트 치료의 보급 확대, 입원 기간 단축에 대한 관심 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 저침습적 BPH 치료 장비의 채택 증가, 레이저를 이용한 전립선 치료의 이용 확대, 임플란트 치료 옵션에 대한 수요 증가, 클리닉 기반 BPH 시술의 확대, 환자의 편안함과 회복에 대한 관심 강화 등을 들 수 있습니다.
전립선암 발생률 증가는 향후 수년간 양성 전립선 비대증(BPH) 시장의 성장을 촉진할 것으로 예측됩니다. 전립선암은 남성의 방광 바로 아래에 위치한 호두 크기의 작은 샘인 전립선에 발생하는 암의 일종입니다. 전립선암 환자가 증가함에 따라 더 많은 고령 남성들이 전립선 관련 질환 치료를 받기 시작했고, 그 결과 BPH의 발견과 관리가 발전하고 있습니다. 예를 들어 미국 임상종양학회(ASCO)가 운영하는 환자 정보 사이트 cancer.net에 따르면 2023년 2월 기준 미국내 전립선암 환자 수는 약 28만 8,300명으로 추산되며, 2022년에는 신규 환자 26만 8,490명, 사망자 수 3만 4,500명, 사망자 수 3 만 4,500건이 보고되었습니다. 그 결과, 전립선암 유병률 증가는 BPH 시장의 확대를 촉진하고 있습니다.
BPH 치료 기기 및 장치 시장에서 사업을 운영하는 주요 기업은 외래 치료를 지원하고 장기적인 약물 복용과 대규모 조직 절제 수술의 필요성을 줄이는 혁신적인 저침습적 솔루션에 초점을 맞추었습니다. 일시적으로 삽입하는 BPH 치료 장치는 전립선비대증으로 인한 하부요로증상(LUTS)을 완화하기 위해 전립선 요도를 재형성하는 단기 또는 1회용 임플란트입니다. 예를 들어 2025년 2월에는 일본의 의료 기술 기업 올림푸스가 태국, 호주, 홍콩, 싱가포르, 인도 등 아시아태평양의 주요 시장에서 iTind 디바이스를 확대 제공한다고 발표했으며, 한국에서도 출시가 예정되어 있습니다. iTind 시술은 국소 마취 하에 시행되는 최소 침습적인 클리닉 기반 옵션을 제공하며, 임상 도입을 촉진하기 위한 종합적인 의사 교육 프로그램을 통해 지원됩니다. 이 장치는 일시적으로 삽입하는 니티놀 소재의 임플란트로, 전립선 요도를 재형성하여 소변의 흐름을 개선하고 환자의 삶의 질을 향상시킵니다. 최근 가이드라인 개정 및 보험 적용 확대 움직임이 가속화되고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 방글라데시 시장
제19장 태국 시장
제20장 베트남 시장
제21장 말레이시아 시장
제22장 싱가포르 시장
제23장 필리핀 시장
제24장 홍콩 시장
제25장 뉴질랜드 시장
제26장 대만 시장
제27장 동남아시아 시장
제28장 서유럽 시장
제29장 영국 시장
제30장 독일 시장
제31장 프랑스 시장
제32장 이탈리아 시장
제33장 스페인 시장
제34장 오스트리아 시장
제35장 벨기에 시장
제36장 덴마크 시장
제37장 핀란드 시장
제38장 아일랜드 시장
제39장 네덜란드 시장
제41장 포르투갈 시장
제42장 스웨덴 시장
제42장 스위스 시장
제43장 동유럽 시장
제44장 러시아 시장
제45장 체코 시장
제46장 폴란드 시장
제47장 루마니아 시장
제48장 우크라이나 시장
제49장 북미 시장
제50장 미국 시장
제51장 캐나다 시장
제52장 멕시코 시장
제53장 남미 시장
제54장 브라질 시장
제55장 칠레 시장
제56장 아르헨티나 시장
제57장 콜롬비아 시장
제58장 페루 시장
제59장 중동 시장
제60장 사우디아라비아 시장
제61장 이스라엘 시장
제62장 이란 시장
제63장 튀르키예 시장
제64장 아랍에미리트 시장
제65장 아프리카 시장
제66장 이집트 시장
제67장 나이지리아 시장
제68장 남아프리카공화국 시장
제69장 시장 규제 상황과 투자환경
제70장 경쟁 구도와 기업 개요
제71장 기타 대기업과 혁신적 기업
제72장 세계의 시장 경쟁 벤치마킹과 대시보드
제73장 주요 합병과 인수
제74장 시장의 잠재력이 높은 국가, 부문, 전략
제75장 부록
KSA
영문 목차
영문목차
Benign Prostatic Hyperplasia (BPH), also known as benign prostatic hypertrophy, signifies the enlargement of the prostate gland leading to urethral blockage, hindering the normal urine flow from the bladder.
The primary offerings in the market for devices and equipment aimed at treating Benign Prostatic Hyperplasia (BPH) include resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. Resectoscopes serve as endoscopic tools employed in surgeries involving the uterus, prostate, bladder, or urethra, enabling the extraction of tissue for biopsy, removal of growths, or ablation of diseased or damaged tissue. Various procedures conducted encompass transurethral needle ablation (TUNA), transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), transurethral microwave thermotherapy (TUMT), laser surgery, among others. The diverse user segments involved in utilizing these products include hospitals, ambulatory surgical centers (ASCs), clinics, and home-based applications.
Tariffs are impacting the BPH treatment devices and equipment market by increasing costs of imported lasers, endoscopic instruments, radiofrequency generators, implants, and precision surgical components. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to reliance on imported urology devices, while Asia-Pacific faces increased production costs for export-oriented equipment. These tariffs are raising procedure costs and influencing purchasing decisions. However, they are also supporting localized manufacturing, regional assembly of urology devices, and long-term development of cost-optimized BPH treatment technologies.
The benign prostatic hyperplasia (bph) treatment devices and equipment market research report is one of a series of new reports from The Business Research Company that provides benign prostatic hyperplasia (bph) treatment devices and equipment market statistics, including benign prostatic hyperplasia (bph) treatment devices and equipment industry global market size, regional shares, competitors with a benign prostatic hyperplasia (bph) treatment devices and equipment market share, detailed benign prostatic hyperplasia (bph) treatment devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the benign prostatic hyperplasia (bph) treatment devices and equipment industry. This benign prostatic hyperplasia (bph) treatment devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The benign prostatic hyperplasia (bph) treatment devices and equipment market size has grown strongly in recent years. It will grow from $1.34 billion in 2025 to $1.43 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing prevalence of benign prostatic hyperplasia, rising awareness of urological disorders, adoption of transurethral procedures, expansion of hospital urology departments, improvements in endoscopic surgical tools.
The benign prostatic hyperplasia (bph) treatment devices and equipment market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing aging male population, rising preference for minimally invasive therapies, expansion of outpatient urology clinics, growing adoption of laser and implant-based treatments, increasing focus on reduced hospital stay. Major trends in the forecast period include increasing adoption of minimally invasive bph treatment devices, rising use of laser-based prostate therapies, growing demand for implant-based treatment options, expansion of office-based bph procedures, enhanced focus on patient comfort and recovery.
The rising incidence of prostate cancer is expected to drive growth in the benign prostatic hyperplasia (BPH) market in the coming years. Prostate cancer is a type of cancer that develops in the prostate gland, a small, walnut-sized gland located just below the bladder in men. An increase in prostate cancer cases often leads more older men to seek medical attention for prostate-related conditions, resulting in the identification and management of BPH. For example, in February 2023, according to the American Society of Clinical Oncology (ASCO), a US-based professional organization providing patient information via cancer.net, an estimated 288,300 men in the United States had prostate cancer in 2023, with 268,490 new cases and 34,500 deaths reported in 2022. Consequently, the growing prevalence of prostate cancer is fueling the expansion of the BPH market.
Major companies operating in the BPH treatment devices and equipment market are focusing on innovative, minimally invasive solutions that support outpatient care and reduce the need for long-term medication or extensive tissue-removal procedures. Temporarily implantable BPH devices are short-term or single-use implants designed to reshape the prostatic urethra and relieve lower urinary tract symptoms (LUTS) caused by an enlarged prostate. For instance, in February 2025, Olympus, a Japan-based medical technology company, announced expanded availability of its iTind device across major APAC markets, including Thailand, Australia, Hong Kong, Singapore, India, and a planned launch in Korea. The iTind procedure offers a minimally invasive, clinic-based option performed under local anesthesia and is supported by a comprehensive physician training program to facilitate clinical adoption. The device is a temporarily implantable nitinol implant that reshapes the prostatic urethra, improving urinary flow and patient quality of life, with recent guideline and reimbursement developments accelerating its adoption.
In October 2023, Laborie Medical Technologies Corp., a US-based medical technology company, acquired Urotronic Inc. for an undisclosed amount. This acquisition enhances Laborie's therapeutic urology portfolio by integrating Urotronic's Optilume drug-coated balloon technology for minimally invasive treatment of urethral strictures and BPH. It also strengthens Laborie's global presence by expanding patient access to advanced, evidence-based urologic treatments and broadening its portfolio of innovative interventional solutions. Urotronic Inc. is a US-based medical equipment manufacturer specializing in BPH treatment devices and equipment.
Major companies operating in the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2025. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The benign prostatic hyperplasia (BPH) treatment devices and equipment market consist of sales of prostatic stents, catheter ablation devices, resectoscopes, radiofrequency ablation devices, urology lasers, and prostatic stents that are used to treat benign prostatic hyperplasia. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses benign prostatic hyperplasia (bph) treatment devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for benign prostatic hyperplasia (bph) treatment devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The benign prostatic hyperplasia (bph) treatment devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Minimally Invasive Bph Treatment Devices
4.2.2 Rising Use Of Laser-Based Prostate Therapies
4.2.3 Growing Demand For Implant-Based Treatment Options
4.2.4 Expansion Of Office-Based Bph Procedures
4.2.5 Enhanced Focus On Patient Comfort And Recovery
5. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Ambulatory Surgical Centers
5.3 Urology Clinics
5.4 Specialty Care Centers
5.5 Home Healthcare Providers
6. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Sub-Segmentation Of Resectoscopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Sub-Segmentation Of Urology Lasers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Holmium Lasers, Diode Lasers, Green Light Lasers
9.7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Sub-Segmentation Of Prostatic Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Sub-Segmentation Of Implants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
12.1. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
13.1. India Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
14.1. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
15.1. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
16.1. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
17.1. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20.1. Vietnam Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
21.1. Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23.1. Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Hong Kong Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
24.1. Hong Kong Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. New Zealand Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
25.1. New Zealand Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. South East Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
27.1. South East Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. South East Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
28.1. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
29.1. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30.1. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. France Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
31.1. France Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33.1. Spain Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Austria Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
34.1. Austria Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
36.1. Denmark Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
37. Finland Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
37.1. Finland Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
39.1. Netherlands Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion40. Norway Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
40.1. Norway Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
41. Portugal Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
41.1. Portugal Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
42. Sweden Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
42.1. Sweden Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
42.1. Switzerland Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
43. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
43.1. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
43.2. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
44. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
44.1. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
46.1. Poland Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
47. Romania Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
47.1. Romania Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
48.1. Ukraine Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
49. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
49.1. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
49.2. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
50. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
50.1. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
50.2. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
52.2. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
53. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
53.1. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
53.2. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
54. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
54.1. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
55.1. Chile Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
56. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
56.1. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
57.1. Colombia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
58. Peru Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
58.1. Peru Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
59. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
59.1. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
59.2. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
60. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
60.1. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
61. Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
61.1. Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
63.1. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
64. United Arab Emirates Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
64.1. United Arab Emirates Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
65. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
65.1. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
65.2. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
67.1. Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
68. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
68.1. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
69. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Regulatory and Investment Landscape
70. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Landscape And Company Profiles
70.1. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Landscape And Market Share 2024
70.1.1. Top 10 Companies (Ranked by revenue/share)
70.2. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market - Company Scoring Matrix
70.2.1. Market Revenues
70.2.2. Product Innovation Score
70.2.3. Brand Recognition
70.3. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Company Profiles
70.3.1. Karl Storz Overview, Products and Services, Strategy and Financial Analysis
70.3.2. Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
70.3.3. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
70.3.4. Urologix LLC Overview, Products and Services, Strategy and Financial Analysis
70.3.5. Boston Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
71. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Other Major And Innovative Companies
NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System
72. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Benchmarking And Dashboard
73. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
74. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market High Potential Countries, Segments and Strategies
74.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2030 - Countries Offering Most New Opportunities
74.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2030 - Segments Offering Most New Opportunities
74.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2030 - Growth Strategies
